Free Trial

BridgeBio Pharma (BBIO) News Today

BridgeBio Pharma logo
$23.41
-0.38 (-1.60%)
(As of 10/31/2024 ET)
BridgeBio Pharma, Inc. stock logo
HC Wainwright Reiterates "Buy" Rating for BridgeBio Pharma (NASDAQ:BBIO)
HC Wainwright reissued a "buy" rating and set a $43.00 target price on shares of BridgeBio Pharma in a research note on Friday.
BridgeBio Pharma, Inc. stock logo
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Rating of "Moderate Buy" by Brokerages
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) have been given a consensus rating of "Moderate Buy" by the fifteen brokerages that are currently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and thirteen have assigned a bu
BridgeBio Pharma, Inc. stock logo
BridgeBio Pharma (NASDAQ:BBIO) PT Lowered to $46.00 at Leerink Partners
Leerink Partners decreased their target price on shares of BridgeBio Pharma from $47.00 to $46.00 and set an "outperform" rating for the company in a report on Thursday.
BridgeBio Pharma, Inc. stock logo
Equities Analysts Offer Predictions for BridgeBio Pharma, Inc.'s Q3 2024 Earnings (NASDAQ:BBIO)
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) - Stock analysts at Leerink Partnrs decreased their Q3 2024 earnings per share (EPS) estimates for BridgeBio Pharma in a note issued to investors on Monday, October 14th. Leerink Partnrs analyst M. Foroohar now forecasts that the company will pos
BridgeBio Pharma, Inc. stock logo
BridgeBio Pharma (NASDAQ:BBIO) Now Covered by Analysts at Scotiabank
Scotiabank initiated coverage on shares of BridgeBio Pharma in a research report on Wednesday. They set a "sector outperform" rating on the stock.
BridgeBio Pharma, Inc. stock logo
BridgeBio Pharma (NASDAQ:BBIO) Shares Up 4.7% - Should You Buy?
BridgeBio Pharma (NASDAQ:BBIO) Stock Price Up 4.7% - Here's What Happened
BridgeBio Pharma, Inc. stock logo
BridgeBio Pharma (NASDAQ:BBIO) Shares Down 4.6% - Here's What Happened
BridgeBio Pharma (NASDAQ:BBIO) Shares Down 4.6% - Time to Sell?
BridgeBio Pharma, Inc. stock logo
Marshall Wace LLP Acquires Shares of 30,849 BridgeBio Pharma, Inc. (NASDAQ:BBIO)
Marshall Wace LLP bought a new position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The fund bought 30,849 shares of the company's stock, valued at approximately $781,000. Several other large investors
BridgeBio Pharma, Inc. stock logo
Algert Global LLC Has $1.42 Million Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO)
Algert Global LLC trimmed its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 37.5% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,848 shares of the company's stock after
BridgeBio Pharma, Inc. stock logo
Ghisallo Capital Management LLC Sells 33,750 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)
Ghisallo Capital Management LLC cut its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 50.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 33,750 shares of the company's stoc
Piper Sandler Keeps Their Buy Rating on BridgeBio Pharma (BBIO)
BridgeBio Pharma, Inc. stock logo
BridgeBio Pharma (NASDAQ:BBIO) Stock Rating Reaffirmed by HC Wainwright
HC Wainwright reaffirmed a "buy" rating and issued a $43.00 target price on shares of BridgeBio Pharma in a report on Monday.
BridgeBio Pharma, Inc. stock logo
Perceptive Advisors LLC Trims Stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO)
Perceptive Advisors LLC lowered its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 13.9% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 1,215,346 shares of the company's stock after selling 196,687 shares during the period. Perceptive Adv
BridgeBio Pharma, Inc. stock logo
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Stake Boosted by Frazier Life Sciences Management L.P.
Frazier Life Sciences Management L.P. grew its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 6.4% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,632,604 shares o
BridgeBio Pharma, Inc. stock logo
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Average Recommendation of "Moderate Buy" from Brokerages
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) have received an average rating of "Moderate Buy" from the twelve analysts that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and eleven have iss
BridgeBio Pharma, Inc. stock logo
Lion Point Capital LP Takes Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)
Lion Point Capital LP acquired a new position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 49,000 shares of the company's stock, valued at approximatel
BridgeBio Pharma, Inc. stock logo
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Sold by Federated Hermes Inc.
Federated Hermes Inc. cut its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 94.3% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,500 shares of the company's stock after selling 75,028 shares during the quarte
BridgeBio Pharma, Inc. stock logo
Ensign Peak Advisors Inc Has $41.70 Million Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)
Ensign Peak Advisors Inc lifted its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 44.5% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 1,646,202 shares of the company's stock after buying an additional 506,845 shares
BridgeBio Pharma, Inc. stock logo
Massachusetts Financial Services Co. MA Increases Stock Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO)
Massachusetts Financial Services Co. MA boosted its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 57.9% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 598,263 shares of the company's stock after purchasing
BridgeBio Pharma, Inc. stock logo
American Century Companies Inc. Buys 182,623 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)
American Century Companies Inc. lifted its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 20.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,096,734 shares of the company's stock after buying an additional 182,623 sha
BridgeBio Pharma, Inc. stock logo
BridgeBio Pharma (NASDAQ:BBIO) Shares Gap Up to $26.19
BridgeBio Pharma (NASDAQ:BBIO) Shares Gap Up to $26.19
BridgeBio Pharma, Inc. stock logo
BridgeBio Pharma's (BBIO) "Overweight" Rating Reiterated at Cantor Fitzgerald
Cantor Fitzgerald reissued an "overweight" rating and issued a $70.00 target price on shares of BridgeBio Pharma in a report on Monday.
BridgeBio Pharma, Inc. stock logo
BridgeBio Pharma's (BBIO) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright restated a "buy" rating and set a $43.00 target price on shares of BridgeBio Pharma in a research report on Monday.
BridgeBio Pharma, Inc. stock logo
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Stock Position Boosted by Daiwa Securities Group Inc.
Daiwa Securities Group Inc. boosted its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 5,393.7% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 35,709 shares of the company's stock after buyi
BridgeBio Pharma, Inc. stock logo
Victory Capital Management Inc. Has $9.69 Million Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO)
Victory Capital Management Inc. raised its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 9.9% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 382,717 shares of the company's stock after purchasing an additional 34,360 shares dur
BridgeBio Pharma, Inc. stock logo
BridgeBio Pharma (NASDAQ:BBIO) Shares Down 2.2%
BridgeBio Pharma (NASDAQ:BBIO) Stock Price Down 2.2%
BridgeBio Pharma, Inc. stock logo
BridgeBio Pharma, Inc. (NASDAQ:BBIO) to Post Q3 2024 Earnings of ($0.85) Per Share, Leerink Partnrs Forecasts
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) - Equities researchers at Leerink Partnrs boosted their Q3 2024 earnings per share (EPS) estimates for BridgeBio Pharma in a report issued on Tuesday, September 10th. Leerink Partnrs analyst M. Foroohar now forecasts that the company will post ea
Get BridgeBio Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBIO and its competitors with MarketBeat's FREE daily newsletter.

Don’t Miss Out! Get 2 Hot AI Stocks for Under $10/Share 🚀 (Ad)

Artificial Intelligence (AI) stocks are booming, and now is your chance to get in on the action — without breaking the bank! We’ve just uncovered 2 must-buy AI stocks trading for under $10/share, and they’re showing serious potential for growth.

Click here to get your FREE report delivered instantly!

BBIO Media Mentions By Week

BBIO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BBIO
News Sentiment

0.30

0.68

Average
Medical
News Sentiment

BBIO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BBIO Articles
This Week

5

6

BBIO Articles
Average Week

Get BridgeBio Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBIO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:BBIO) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners